Showing results (471-480 of 601) with videos related to

Sort By:
Pageof 61
European Journal of Haematology|November 25, 2014
Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA studyYesim Aydinok, John B Porter, Antonio Piga, et al.
British Journal of Haematology|September 1, 1993
Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating siteJ B Porter, R D Abeysinghe, K P Hoyes, et al.
The American Journal of Cardiology|June 1, 1985
Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adultsD R Holmes, G K Danielson, B J Gersh, et al.
Pediatric Blood & Cancer|September 1, 2016
One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantationAdlette Inati, Mario Kahale, Nada Sbeiti, et al.
Lancet (London, England)|September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialJ L Rouleau, M A Pfeffer, D J Stewart, et al.
Haematologica|December 22, 2010
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overloadHugh Young Rienhoff, Vip Viprakasit, Lay Tay, et al.
The New England Journal of Medicine|October 21, 1993
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow supportO W Press, J F Eary, F R Appelbaum, et al.
Annals of Hematology|October 23, 2012
Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudyJ B Porter, M S Elalfy, A T Taher, et al.
Arthritis Research & Therapy|May 4, 2019
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance dataA Deodhar, P J Mease, I B McInnes, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 15, 2005
Endurance training increases skeletal muscle LKB1 and PGC-1alpha protein abundance: effects of time and intensityEric B Taylor, Jeremy D Lamb, Richard W Hurst, et al.
Pageof 61